Comparative Pharmacology
Head-to-head clinical analysis: AK FLUOR 25 versus LYMPHAZURIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AK FLUOR 25 versus LYMPHAZURIN.
AK-FLUOR 25% vs LYMPHAZURIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Sodium fluorescein absorbs light in the blue spectrum (465-490 nm) and emits yellow-green fluorescence (520-530 nm), enabling visualization of the retinal and choroidal vasculature by highlighting areas of vascular leakage, staining defects, or filling defects.
Lymphazurin is a diagnostic dye composed of isosulfan blue. It is a hydrophilic molecule that selectively binds to serum albumin and is preferentially taken up by lymphatic vessels. When injected subcutaneously or intradermally, it enters the lymphatic system and stains the lymphatic vessels and nodes, allowing for visual identification during lymph node mapping and sentinel lymph node biopsy procedures.
Intravenous administration: 5-15 mg/kg as a single bolus injection over 1-2 minutes. For ophthalmic use: 1-2 drops of 2% fluorescein solution topically.
0.1 mL (100 mcg) administered via submucosal injection in 3 divided doses into the distal submucosa surrounding the cervical os (12, 4, and 8 o'clock positions) at a depth of 3 mm, 10 minutes prior to the procedure.
None Documented
None Documented
Terminal half-life: 1-2 minutes (fluorescence decay); clinical context: transient plasma fluorescence, minimal systemic accumulation
Terminal elimination half-life is 18–24 hours; prolonged in renal impairment (up to 40 hours in severe impairment), requiring dose adjustment.
Renal: >90% unchanged within 24-48 hours; <10% fecal via biliary elimination
Primarily renal excretion as unchanged drug (approximately 70%) and as glucuronide conjugate (20%); negligible biliary or fecal elimination (<5%).
Category C
Category C
Diagnostic Dye
Diagnostic Dye